STANDEX INTERNATIONAL CORP/DE/ has recently released its 10-K report, providing an insight into its diverse industrial manufacturing operations. The company operates through five segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. In the report, the company highlighted several strategic acquisitions, including McStarlite Co., Nascent Technology Manufacturing, Custom Biogenic Systems, Amran/Narayan Group, Sanyu Electric Pte Ltd, Sanyu Switch Co., Ltd, and Minntronix. These acquisitions significantly expanded the company's sales in various high-margin markets.
The company's consolidated results from continuing operations for the fiscal year 2025 showed a net sales increase of $69.5 million, reaching $790.1 million, with a gross profit margin of 39.9%. However, it reported restructuring costs of $6.9 million and acquisition-related expenses of $21.4 million. Income from operations for the fiscal year 2025 was $93.5 million, a decrease of $8.2 million compared to the prior year.
The report also discussed the performance of each reportable segment. For instance, the Electronics segment experienced organic sales decrease due to economic softness in Europe and North America, while the Scientific segment was impacted by the National Institutes of Health funding cuts. The company also outlined its interest expense, income taxes, and various factors affecting its effective tax rates.
As a result of these announcements, the company's shares have moved 9.97% on the market, and are now trading at a price of $181.16. For the full picture, make sure to review STANDEX INTERNATIONAL CORP/DE/'s 10-K report.
